Boston Scientific Corporation has voluntarily recalled 7,098 units of AXIOS Stent and Delivery Systems, including Electrocautery-Enhanced and "HOT" AXIOS models. The recall is due to a risk where the black tip at the end of the device may detach and remain inside the body, potentially preventing the stent from opening correctly. While no injuries have been reported, this defect can cause surgical procedures to take longer as doctors must exchange the faulty device for a new one. The affected medical devices were distributed nationwide and in Puerto Rico.
The distal black tip of the device sheath can detach and become stuck on the stent saddle, which prevents the stent from expanding as intended during placement. This complication requires medical staff to prolong the procedure to remove and replace the delivery system, which may increase the duration of anesthesia or surgery for the patient.
Quantity: 495 units US; 2 units (OUS)
Quantity: 1144 units US; 60 units (OUS)
Quantity: 1399 units; 20 units (OUS)
Quantity: 309 units
Quantity: 31 units
Quantity: 47 units
Quantity: 12 units
Quantity: 38 units
Quantity: 263 units (OUS)
Quantity: 91 units (OUS)
Quantity: 519 units (OUS)
Quantity: 1530 units (OUS)
Quantity: 1102 units (OUS)
Quantity: 118 units (OUS)
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.